Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future

Clin Mol Hepatol. 2023 Apr;29(2):394-397. doi: 10.3350/cmh.2023.0104. Epub 2023 Apr 1.
No abstract available

Keywords: Fibrosis; Imaging; NAFLD; Noninvasive; Steatosis.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Biomarkers
  • Humans
  • Liver / diagnostic imaging
  • Non-alcoholic Fatty Liver Disease* / complications
  • Non-alcoholic Fatty Liver Disease* / diagnosis

Substances

  • Biomarkers